John F. Burd
Technik-/Wissenschafts-/F&E-Leiter bei Freedom Meditech, Inc.
Profil
John F.
Burd is the founder.
He founded Oculir, Inc. in 2003 and DexCom, Inc. in 1999.
At Oculir, Inc., he held the title of President & Chief Executive Officer in 2008.
At DexCom, Inc., he also held the title of President & Chief Executive Officer from 1999 to 2002.
Dr. Burd is also the founder of LXN Corp.
Dr. Burd's current job is at Freedom Meditech, Inc. where he started in 2008 and currently holds the position of Chief Science Officer.
Dr. Burd's former jobs include Vice President-Research & Development at Quidel Corp., Principal at Bayer Corp., Chief Operating Officer & Executive Vice President at MAST Immunosystems, Inc., and General Partner at Windamere Venture Partners LLC.
Dr. Burd's education includes an undergraduate degree from Purdue University and graduate and doctorate degrees from the University of Wisconsin.
Dr. Burd is also the founder of LXN Corp.
Aktive Positionen von John F. Burd
Unternehmen | Position | Beginn |
---|---|---|
Freedom Meditech, Inc.
Freedom Meditech, Inc. Medical SpecialtiesHealth Technology Freedom Meditech, Inc. operates as a medical device company which focuses on the development and commercialization of ophthalmic medical devices. It specializes in devices for the detection, monitoring, and management of chronic diseases, such as diabetes. The company was founded by Craig H. Misrach and Keith D. Ignotz in December 2006 and is headquartered in San Diego, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2010 |
Ehemalige bekannte Positionen von John F. Burd
Unternehmen | Position | Ende |
---|---|---|
Oculir, Inc.
Oculir, Inc. Medical SpecialtiesHealth Technology Oculir, Inc. develops medical devices. It develops products such as non-invasive glucose meter to measure glucose from white part of the human eye (the conjunctiva). The company was founded by John Burd and David A. Socks in 2003 and is headquartered in San Diego, CA. | Vorstandsvorsitzender | 23.10.2008 |
Windamere Venture Partners LLC
Windamere Venture Partners LLC Investment ManagersFinance Windamere Venture Partners LLC (Windamere Venture Partners) is an independent venture capital firm founded in 1999 by Scott L. Glenn. The firm is headquartered in San Diego. | Corporate Officer/Principal | 31.12.2007 |
DEXCOM, INC. | Vorstandsvorsitzender | 01.01.2002 |
Bayer Corp.
Bayer Corp. Pharmaceuticals: MajorHealth Technology Bayer Corp. manufactures and markets pharmaceutical, healthcare, nutrition and materials products. The firm offers consumer care, diagnostics, diabetes and animal health products. It also provides material science products, which include coating, adhesive and sealant raw materials polycarbonates polyurethanes and thermoplastic polyurethane elastomers. The company was founded in 1973 and is based in Whippany, NJ. | Corporate Officer/Principal | - |
MAST Immunosystems, Inc.
MAST Immunosystems, Inc. Medical SpecialtiesHealth Technology Part of Resonac Holdings Corp., MAST Immunosystems, Inc. is a company that specializes in providing quality allergy care through their comprehensive panel test for environmental and food allergens called OPTIGEN® Allergen-Specific IgE Assay. The company is based in Mountain View, CA. The company also offers the OPTIGEN® Multiplex Allergen-Specific IgE Assay and the AP3600™ Fully-Automated System for OPTIGEN Allergy. MAST Immunosystems was acquired by Resonac Corp., part of Resonac Holdings Corp. from April 20, 2020 on November 04, 1996 for $40 million. | Geschäftsführer | - |
Ausbildung von John F. Burd
Purdue University | Undergraduate Degree |
University of Wisconsin | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
DEXCOM, INC. | Health Technology |
Private Unternehmen | 7 |
---|---|
Quidel Corp.
Quidel Corp. Medical SpecialtiesHealth Technology Quidel Corp. engages in the development, manufacture and market of rapid diagnostic testing solutions. Its portfolio includes rapid immunoassays, cardiac immunoassays, specialized diagnostic solutions and molecular diagnostic solutions. The firm products are directly sold to end users and distributors and for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies and wellness screening centers. The company was founded in 1979 and is headquartered in San Diego, CA. | Health Technology |
Bayer Corp.
Bayer Corp. Pharmaceuticals: MajorHealth Technology Bayer Corp. manufactures and markets pharmaceutical, healthcare, nutrition and materials products. The firm offers consumer care, diagnostics, diabetes and animal health products. It also provides material science products, which include coating, adhesive and sealant raw materials polycarbonates polyurethanes and thermoplastic polyurethane elastomers. The company was founded in 1973 and is based in Whippany, NJ. | Health Technology |
LXN Corp
LXN Corp Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, LXN Corp is a company that develops and commercializes fructosamine monitoring technology for diabetes. The company is based in San Diego, CA. The company was founded by John F. Burd. LXN was acquired by Inverness Medical Technology, Inc. on March 29, 2001 for $18.48 million. | Health Technology |
Oculir, Inc.
Oculir, Inc. Medical SpecialtiesHealth Technology Oculir, Inc. develops medical devices. It develops products such as non-invasive glucose meter to measure glucose from white part of the human eye (the conjunctiva). The company was founded by John Burd and David A. Socks in 2003 and is headquartered in San Diego, CA. | Health Technology |
MAST Immunosystems, Inc.
MAST Immunosystems, Inc. Medical SpecialtiesHealth Technology Part of Resonac Holdings Corp., MAST Immunosystems, Inc. is a company that specializes in providing quality allergy care through their comprehensive panel test for environmental and food allergens called OPTIGEN® Allergen-Specific IgE Assay. The company is based in Mountain View, CA. The company also offers the OPTIGEN® Multiplex Allergen-Specific IgE Assay and the AP3600™ Fully-Automated System for OPTIGEN Allergy. MAST Immunosystems was acquired by Resonac Corp., part of Resonac Holdings Corp. from April 20, 2020 on November 04, 1996 for $40 million. | Health Technology |
Windamere Venture Partners LLC
Windamere Venture Partners LLC Investment ManagersFinance Windamere Venture Partners LLC (Windamere Venture Partners) is an independent venture capital firm founded in 1999 by Scott L. Glenn. The firm is headquartered in San Diego. | Finance |
Freedom Meditech, Inc.
Freedom Meditech, Inc. Medical SpecialtiesHealth Technology Freedom Meditech, Inc. operates as a medical device company which focuses on the development and commercialization of ophthalmic medical devices. It specializes in devices for the detection, monitoring, and management of chronic diseases, such as diabetes. The company was founded by Craig H. Misrach and Keith D. Ignotz in December 2006 and is headquartered in San Diego, CA. | Health Technology |